Get the Stockscreener App
7.53
4.40%
-0.42
Capsovision Inc stock is traded at $7.53, with a volume of 508.67K.
It is down -4.40% in the last 24 hours and up +10.14% over the past month.
CapsoVision Inc is a commercial-stage medical technology enterprise, innovates, manufactures, and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal (GI) system. Internal GI imaging facilitates earlier detection of colorectal cancer and other diseases, enabling more timely and effective treatment regimens for patients. The Company's core technology platform is an orally ingestable capsule including multiple cameras facilitating 360-degree imaging, light-emitting diodes for measurement, onboard memory storage, and battery life permitting recording and onboard storage of video images. The Company's products consist of the on-market CapsoCam Plus, directed at the small intestines, and the in-development CapsoColon 3D directed at the large intestines.
See More
Previous Close:
$7.95
Open:
$7.96
24h Volume:
508.67K
Relative Volume:
3.27
Market Cap:
$354.37M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-28.91%
1M Performance:
+10.14%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$7.3301
$8.05
1-Week Range:
$7.3301
$11.37
52-Week Range:
$3.4341
$15.37
Capsovision Inc Stock (CV) Company Profile
Name
Capsovision Inc
Sector
Industry
Phone
(408) 370-4790
Address
18805 COX AVENUE SUITE 250, SARATOGA
Compare CV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CV
Capsovision Inc
|
7.565 | 372.40M | 0 | 0 | 0 | 0.00 |
|
ABT
Abbott Laboratories
|
127.03 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.64 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.64 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.78 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.58 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Capsovision Inc Stock (CV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-28-25 | Initiated | Roth Capital | Buy |
| Jul-28-25 | Initiated | The Benchmark Company | Speculative Buy |
Capsovision Inc Stock (CV) Latest News
CapsoVision submits FDA 510(k) for AI-assisted module in CapsoCam Plus - MSN
US Smart Pills Market to Reach US$ 619.10 Million by 2033 | CAGR - openPR.com
CapsoVision prices $27.5M IPO - MSN
CapsoVision Submits FDA 510(k) for AI-Assisted Module in CapsoCam Plus - Yahoo Finance
CapsoVision (NASDAQ:CV) Shares Gap DownHere's Why - MarketBeat
CapsoVision, Inc.'s (NASDAQ:CV) Path To Profitability - 富途牛牛
CapsoVision price target raised to $14 from $5 at Benchmark - TipRanks
CapsoVision Shares Rise After Company Files 510(k) With US FDA to Add AI-Assisted Module to CapsoCam Plus - marketscreener.com
CapsoVision (NASDAQ:CV) Shares Gap UpHere's What Happened - MarketBeat
CapsoVision, ACM Research And Other Big Stocks Moving Higher On Tuesday - Benzinga
Verastem, TEN Holdings And 3 Stocks To Watch Heading Into Tuesday - Benzinga
CapsoVision Stock Pre-Market (-11%) : FDA 510(k) Submission for AI Module - Trefis
CapsoVision submits FDA application for AI-assisted capsule endoscopy By Investing.com - Investing.com Nigeria
CapsoVision submits FDA application for AI-assisted capsule endoscopy - Investing.com
CapsoVision Seeks FDA Clearance for AI Endoscopy Module - TipRanks
CapsoVision Files 510(k) With US FDA to Add AI-Assisted Module to CapsoCam Plus - marketscreener.com
CapsoVision Announces 510(k) Submission for the Addition of AI-Assisted Reading Module in CapsoCam Plus® - The Manila Times
CapsoVision, Inc Submits 510(k) Application for AI Module - TradingView — Track All Markets
Certain Common Stock of CapsoVision, Inc. are subject to a Lock-Up Agreement Ending on 29-DEC-2025. - marketscreener.com
Certain Stock Options of CapsoVision, Inc. are subject to a Lock-Up Agreement Ending on 29-DEC-2025. - marketscreener.com
Certain Warrants of CapsoVision, Inc. are subject to a Lock-Up Agreement Ending on 29-DEC-2025. - marketscreener.com
CapsoVision (NASDAQ:CV) Shares Down 6.5% – Time to Sell? - Defense World
CapsoVision, Inc. (NASDAQ:CV) Short Interest Up 171.0% in December - MarketBeat
CapsoVision (NASDAQ:CV) Trading Down 6.5%Here's Why - MarketBeat
CapsoVision (NASDAQ:CV) Trading Up 12.9%Here's Why - MarketBeat
Honeywell, Intuitive Machines And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Sahm
Sidus Space, Starfighters Space And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Sahm
CapsoVision, Inc.’s Lock-Up Period Set To End on December 29th (NASDAQ:CV) - Defense World
CapsoVision Inc Trading Resumes - MSN
CapsoVision (NASDAQ:CV) Trading Down 3.1%Time to Sell? - MarketBeat
CapsoVision (NASDAQ:CV) Trading Up 7.3%Here's Why - MarketBeat
12 Health Care Stocks Moving In Monday's Pre-Market Session - Benzinga
Return on assets % of CapsoVision, Inc. – DUS:H6U - TradingView — Track All Markets
CapsoVision (NASDAQ:CV) Trading Down 15%Here's Why - MarketBeat
CapsoVision Announces Leadership Transition Plans - MSN
Broadcom, LightPath Technologies, Netskope And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Sahm
CapsoVision Stock Surges 161%, With A 7-Day Winning Spree - Trefis
CapsoVision (NASDAQ:CV) Hits New 1-Year HighHere's Why - MarketBeat
ETFs Investing in CapsoVision, Inc. Stocks - TradingView — Track All Markets
CapsoVision (NASDAQ: CV) Stock Rockets After-Hours: Price Action, Q3 Earnings and 2026 Outlook - ts2.tech
Oxford Industries, Ur-Energy, Oracle And Other Big Stocks Moving Lower In Thursday's Pre-Market Session - Benzinga
Is CapsoVision Showing How Far A Single Capsule Can Take A Med-Tech Company? - RTTNews
CapsoVision Stock Rockets 114% With 6-Day Winning Streak - Trefis
What Sparked CapsoVision's (CV) 53% Surge In After-Hours Trading? - Sahm
CapsoVision Stock Jump Looks Great, But How Secure Is That Gain? - Trefis
A look into CapsoVision Inc (CV)’s deeper side - setenews.com
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
CapsoVision (NASDAQ:CV) Trading 51% HigherShould You Buy? - MarketBeat
Top Gainers on the US Stock Market Today (December 9, 2025): AFJK, NCPL, XCUR, ALEX and More Surge as Fed Meeting Looms - ts2.tech
CapsoVision Welcomes David Garcia to its Senior Executive Team - Medical Product Outsourcing
CapsoVision (CV) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Capsovision Inc Stock (CV) Financials Data
There is no financial data for Capsovision Inc (CV). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
1.20%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):